<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32805420</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1519</ISSN><JournalIssue CitedMedium="Internet"><Volume>282</Volume><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Respiratory physiology &amp; neurobiology</Title><ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Respiratory pathology in the Optn<sup>-/-</sup> mouse model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>103525</StartPage><MedlinePgn>103525</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resp.2020.103525</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1569-9048(20)30183-X</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder that results in death due to respiratory failure. Many genetic defects are associated with ALS; one such defect is a mutation in the gene encoding optineurin (OPTN). Using an optineurin null mouse (Optn<sup>-/-</sup>), we sought to characterize the impact of optineurin deficiency on respiratory neurodegeneration. Respiratory function was assessed at 6 and 12 mo of age using whole body plethysmography at baseline during normoxia (FiO<sub>2</sub>: 0.21; N<sub>2</sub> balance) and during a respiratory challenge with hypoxia and hypercapnia (FiCO<sub>2</sub>: 0.07, FiO<sub>2</sub>: 0.10; N<sub>2</sub> balance). Histological analyses to assess motor neuron viability and respiratory nerve integrity were performed in the medulla, cervical spinal cord, hypoglossal nerve, and phrenic nerve. Minute ventilation, peak inspiratory flow, and peak expiratory flow are significantly reduced during a respiratory challenge in 6 mo Optn<sup>-/-</sup>mice. By 12 mo, tidal volume is also significantly reduced in Optn<sup>-/-</sup> mice. Furthermore, 12mo Optn<sup>-/-</sup> mice exhibit hypoglossal motor neuron loss, phrenic and hypoglossal dysmyelination, and accumulated mitochondria in the hypoglossal nerve axons. Overall, these data indicate that Optn<sup>-/-</sup> mice display neurodegenerative respiratory dysfunction and are a useful model to study the impact of novel therapies on respiratory function for optineurin-deficient ALS patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCall</LastName><ForeName>Angela L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhindsa</LastName><ForeName>Justin S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pucci</LastName><ForeName>Logan A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Amanda F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusco</LastName><ForeName>Anna F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biswas</LastName><ForeName>Debolina D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Henry C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Duke Eye Center and Department of Ophthalmology, School of Medicine, Duke University, Durham, North Carolina 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>ElMallah</LastName><ForeName>Mai K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center Box 2644, Durham, North Carolina 27710, USA. Electronic address: mai.elmallah@duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS098131</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS112781</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Respir Physiol Neurobiol</MedlineTA><NlmUniqueID>101140022</NlmUniqueID><ISSNLinking>1569-9048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501288">Optn protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Respir Physiol Neurobiol. 2020 Nov 16;:103570</RefSource><PMID Version="1">33214085</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007002" MajorTopicYN="N">Hypoglossal Nerve</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010791" MajorTopicYN="N">Phrenic Nerve</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">optineurin</Keyword><Keyword MajorTopicYN="N">respiration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32805420</ArticleId><ArticleId IdType="mid">NIHMS1622815</ArticleId><ArticleId IdType="pmc">PMC7530116</ArticleId><ArticleId IdType="doi">10.1016/j.resp.2020.103525</ArticleId><ArticleId IdType="pii">S1569-9048(20)30183-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH &amp; Al-Chalabi A Amyotrophic Lateral Sclerosis. N Engl J Med 377, 162&#x2013;172 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Fregosi RF &amp; Fuller DD Respiratory-related control of extrinsic tongue muscle activity. Respir Physiol 110, 295&#x2013;306 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9407623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gestreau C, Dutschmann M, Obled S &amp; Bianchi AL Activation of XII motoneurons and premotor neurons during various oropharyngeal behaviors. Respir Physiol Neurobiol 147, 159&#x2013;176 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15919245</ArticleId></ArticleIdList></Reference><Reference><Citation>Remmers JE, deGroot WJ, Sauerland EK &amp; Anch AM Pathogenesis of upper airway occlusion during sleep. J Appl Physiol Respir Environ Exerc Physiol 44, 931&#x2013;938 (1978).</Citation><ArticleIdList><ArticleId IdType="pubmed">670014</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco AF, et al. The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. J Neuroinflamm Neurodegener Dis 3(2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938301</ArticleId><ArticleId IdType="pubmed">31893284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind LA, Murphy ER, Lever TE &amp; Nichols NL Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to Dysphagia. Neuroscience 390, 303&#x2013;316 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168367</ArticleId><ArticleId IdType="pubmed">30179644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, et al. Ventilatory control in ALS. 189, 429&#x2013;437 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4361018</ArticleId><ArticleId IdType="pubmed">23692930</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR &amp; Kirby J The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis 6, 49&#x2013;64 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223&#x2013;226 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A, et al. Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Progress in neurobiology 154, 1&#x2013;20 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H &amp; Yue BY Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 294, 223&#x2013;258 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673586</ArticleId><ArticleId IdType="pubmed">22364875</ArticleId></ArticleIdList></Reference><Reference><Citation>Slowicka K, Vereecke L &amp; van Loo G Cellular Functions of Optineurin in Health and Disease. Trends Immunol 37, 621&#x2013;633 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27480243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353, 603&#x2013;608 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth RP &amp; Atkin JD Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. Front Immunol 9, 1017 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5974248</ArticleId><ArticleId IdType="pubmed">29875767</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen DKH, Thombre R &amp; Wang J Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci Lett 697, 34&#x2013;48 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bo R, et al. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry 82, 1239&#x2013;1243 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21613650</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, et al. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 33, 1016.e1011&#x2013;1017 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21802176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumer Z, et al. Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol Aging 33, 208.e201&#x2013;205 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21852022</ArticleId></ArticleIdList></Reference><Reference><Citation>Weishaupt JH, et al. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol Aging 34, 1516.e1519&#x2013;1515 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23062601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SW, et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget&#x2019;s disease. Cell death and differentiation (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205997</ArticleId><ArticleId IdType="pubmed">31076632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S-W, et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget&#x2019;s disease. Cell Death &amp; Differentiation (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205997</ArticleId><ArticleId IdType="pubmed">31076632</ArticleId></ArticleIdList></Reference><Reference><Citation>DeRuisseau LR, et al. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proceedings of the National Academy of Sciences of the United States of America 106, 9419&#x2013;9424 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695054</ArticleId><ArticleId IdType="pubmed">19474295</ArticleId></ArticleIdList></Reference><Reference><Citation>ElMallah MK, et al. Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9. Human gene therapy methods 23, 148&#x2013;156 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015220</ArticleId><ArticleId IdType="pubmed">22693957</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk DJ, et al. Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Molecular therapy : the journal of the American Society of Gene Therapy 21, 1661&#x2013;1667 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3776643</ArticleId><ArticleId IdType="pubmed">23732990</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebbels S, et al. Elevated Phosphatidylinositol 3,4,5-Trisphosphate in Glia Triggers Cell-Autonomous Membrane Wrapping and Myelination. 30, 8953&#x2013;8964 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632897</ArticleId><ArticleId IdType="pubmed">20592216</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TD, Dash PK, Liu J &amp; Waxham MN Morphology of mitochondria in spatially restricted axons revealed by cryo-electron tomography. PLoS Biol 16, e2006169 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6160218</ArticleId><ArticleId IdType="pubmed">30222729</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettner GM, et al. Spontaneous central apneas occur in the C57BL/6J mouse strain. Respir Physiol Neurobiol 160, 21&#x2013;27 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17869191</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L, et al. Restrictive Lung Disease in the Cu/Zn Superoxide-Dismutase 1 G93A Amyotrophic Lateral Sclerosis Mouse Model. American journal of respiratory cell and molecular biology 56, 405&#x2013;408 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359540</ArticleId><ArticleId IdType="pubmed">28248134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankersley CG, Haenggeli C &amp; Rothstein JD Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. Journal of applied physiology (Bethesda, Md. : 1985) 102, 926&#x2013;932 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17110520</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, et al. Impaired respiratory function in mdx and mdx/utrn(+/&#x2212;) mice. Muscle &amp; nerve 43, 263&#x2013;267 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3103944</ArticleId><ArticleId IdType="pubmed">21254093</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanacore N, Cocco P, Fadda D &amp; Dosemeci M Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotroph Lateral Scler 11, 430&#x2013;434 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20698805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci M, et al. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Neurobiology of disease 37, 370&#x2013;383 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19874893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Satriotomo I, Harrigan DJ &amp; Mitchell GS Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS. Experimental neurology 273, 138&#x2013;150 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644466</ArticleId><ArticleId IdType="pubmed">26287750</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L, et al. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience 291, 216&#x2013;229 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimchinsky EA, et al. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. The Journal of comparative neurology 416, 112&#x2013;125 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10578106</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenggeli C &amp; Kato AC Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci Lett 335, 39&#x2013;43 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12457737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong YC &amp; Holzbaur EL Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proceedings of the National Academy of Sciences of the United States of America 111, E4439&#x2013;4448 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M, et al. Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein. The Journal of biological chemistry 293, 132&#x2013;147 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5766911</ArticleId><ArticleId IdType="pubmed">29133525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan TA &amp; Tumbarello DA Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy. Front Immunol 9, 1024 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962687</ArticleId><ArticleId IdType="pubmed">29867991</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefa U, et al. Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regen Res 14, 749&#x2013;756 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375051</ArticleId><ArticleId IdType="pubmed">30688256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D, Xu J, Kim JS, Dunn WA Jr. &amp; Leeuwenburgh C Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity. Autophagy 9, 328&#x2013;344 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590254</ArticleId><ArticleId IdType="pubmed">23298947</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, et al. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron 93, 1015&#x2013;1034 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerencser AA, Doczi J, Torocsik B, Bossy-Wetzel E &amp; Adam-Vizi V Mitochondrial swelling measurement in situ by optimized spatial filtering: astrocyte-neuron differences. Biophys J 95, 2583&#x2013;2598 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2517017</ArticleId><ArticleId IdType="pubmed">18424491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H &amp; Chan DC Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet 18, R169&#x2013;176 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758711</ArticleId><ArticleId IdType="pubmed">19808793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W, Pasinelli P &amp; Trotti D Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta 1842, 1295&#x2013;1301 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074562</ArticleId><ArticleId IdType="pubmed">24568860</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J &amp; Xu Z Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18, 3241&#x2013;3250 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>